CATS - Catasys, Inc.
| Previous Close | 17.15 |
| Open | 17.05 |
| Bid | 11.19 x 2900 |
| Ask | 0.00 x 1100 |
| Day's Range | 16.81 - 17.80 |
| 52 Week Range | 9.50 - 20.83 |
| Volume | 67,528 |
| Avg. Volume | 98,938 |
| Market Cap | 290.573M |
| Beta (5Y Monthly) | 1.69 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.13 |
| Earnings Date | Nov 12, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 25.00 |
- Simply Wall St.
Is Catasys, Inc.'s (NASDAQ:CATS) CEO Overpaid Relative To Its Peers?
Terren Peizer became the CEO of Catasys, Inc. (NASDAQ:CATS) in 2003. First, this article will compare CEO compensation...
- Insider Monkey
Hedge Funds Have Never Been This Bullish On Catasys, Inc. (CATS)
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period […]
- Business Wire
Catasys Expands OnTrak-A Solution With Leading National Health Plan Into California
Catasys, Inc. (NASDAQ: CATS) ("Catasys" or the "Company"), a leading AI and technology-enabled healthcare company, today announced the expansion of its OnTrak-A solution with a leading national health plan into California beginning January 31, 2020. This expansion ensures that eligible commercial members of the health plan in California will have access to critical behavioral healthcare to help them better manage chronic disease. This is the first of several planned OnTrak-A expansions in 2020.
- Business Wire
Curt Medeiros, President of OPTUM Advanced Data and Analytics at UnitedHealth Group, Joins Catasys as President and Chief Operating Officer
Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced the appointment of Mr. Curt Medeiros as President and Chief Operating Officer.
- Thomson Reuters StreetEvents
Edited Transcript of CATS earnings conference call or presentation 13-Nov-19 9:30pm GMT
Q3 2019 Catasys Inc Earnings Call
- Business Wire
Catasys Appoints Industry Executive Gus Giraldo to Board of Directors
Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced the appointment of Mr. Gustavo Giraldo to its Board of Directors, replacing Ms.
- Simply Wall St.
Catasys, Inc. Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates
It's been a good week for Catasys, Inc. (NASDAQ:CATS) shareholders, because the company has just released its latest...
- Business Wire
Catasys Announces 2019 Third Quarter Financial Results
SANTA MONICA, Calif.-- -- Q3 2019 Record Revenue of $8.8 Million, Up 102% Year over Year and 15% from Q2 2019 Total Outreach Pool of Eligible Members of 140,000 in Q3 2019, Up 26% from 112,000 at Q2 2019 Net New Enrolled Members of 1,473 in Q3 2019, up 366% from 316 in the Same Period of Prior Year Secured $45 Million in Debt Financing from Goldman Sachs to Support Company’s Accelerating Growth Company ...
- Insider Monkey
Hedge Funds Have Never Been More Bullish On Catasys, Inc. (CATS)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out […]
- Business Wire
Catasys Schedules 2019 Third Quarter Financial Results Conference Call for November 13, 2019
Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced that the Company will be releasing financial results for its third quarter ended September 30, 2019, after the closing of the stock market on Wednesday, November 13, 2019.
- Simply Wall St.
How Does Investing In Catasys, Inc. (NASDAQ:CATS) Impact The Volatility Of Your Portfolio?
If you own shares in Catasys, Inc. (NASDAQ:CATS) then it's worth thinking about how it contributes to the volatility...
- Business Wire
Catasys to Present at Credit Suisse 28th Annual Healthcare Conference
Catasys, Inc. (CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that Mr. Terren Peizer, the Company’s Chairman and CEO, is scheduled to present at the 28th Annual Healthcare Conference on Tuesday, November 12, 2019, at 4:10 p.m. MST. Catasys, Inc. is a leading AI and technology-enabled healthcare company whose mission is to help improve the health and save the lives of as many people as possible. By combining predictive analytics with human engagement, Catasys delivers improved member health and validated outcomes and savings to healthcare payers.
- Benzinga
14 Low Float Stocks With High Short Interest
Low float stocks can be some of the most volatile stocks in the market. If you mix in a short squeeze, the potential short-term gains in a low float stock can be extreme. A stock’s float is the number ...
- Thomson Reuters StreetEvents
Edited Transcript of CATS earnings conference call or presentation 14-Aug-19 8:30pm GMT
Q2 2019 Catasys Inc Earnings Call
- Simply Wall St.
Catasys (NASDAQ:CATS) Is Making Moderate Use Of Debt
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Motley FoolCATASYS INC (CATS) Q2 2019 Earnings Call Transcript
CATS earnings call for the period ending June 30, 2019.
- Benzinga
Q2 Earnings Preview For Catasys
On Wednesday, August 14, Catasys (NASDAQ: CATS ) will report its last quarter's earnings. Here is Benzinga's preview of the company's release. Earnings and Revenue Sell-side analysts are expecting Catasys's ...
- GlobeNewswire
BriaCell Appoints Richard J. Berman to Board of Directors
BERKELEY, Calif., and VANCOUVER, British Columbia, Aug. 12, 2019 -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage.
- Zacks
Analysts Estimate Catasys (CATS) to Report a Decline in Earnings: What to Look Out for
Catasys (CATS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
